Efficacy and Safety of Symbravo® in Participants with Migraine Experiencing an Inadequate Response to Oral CGRP Inhibitors

episode

Neurology Minute not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Looking in the Mirror: The Moth Podcast 18 min · 25 Sep 2026 · The Moth

Trump hosts President Xi at state banquet 31 min · 25 Sep 2026 · Global News Podcast

TNA Reaction: Sawyer & Shaw Arrive 18 min · 25 Sep 2026 · Busted Open

12AM ET 09/25/2026 Newscast 3 min · 25 Sep 2026 · Fox News Hourly Update

New Music Friday: The best albums out Sept. 25 44 min · 25 Sep 2026 · NPR Music

r/Bestof My Sister is a Nutjob 18 min · 25 Sep 2026 · rSlash

Report any issue

Source

Recorded20 Aug 2025

Publisherneurologyminute.libsyn.com ↗

Handlerec:10217382

Show notes

Dr. Bradley Ong shares early insights from the EMERGE trial, presented at the American Headache Society's 67th Annual Scientific Meeting in June 2025. Show reference: https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14957

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related